HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074
Philip J. Palumbo(Johns Hopkins University), Susan H. Eshleman(Johns Hopkins University), Jessica M. Fogel(Johns Hopkins University), Latifah Anandari(University of Indonesia), Kostyantyn Dumchev(Ukrainian Institute of Public Health Policy), Estelle Piwowar‐Manning(Johns Hopkins University), Trần Việt Hà(University of North Carolina at Chapel Hill), Autumn Breaud(Johns Hopkins University), Ngô Thị Hoa(Pham Ngoc Thach University of Medicine), William C. Miller(Hennepin Healthcare Research Institute), Paul Richardson(University of Liverpool), Erica L. Hamilton(Family Health International 360), Stephen A. Hart(Nationwide Children's Hospital), Brett Hanscom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Zubairi Djoerban(University of Indonesia), Xu Guo(Shandong Academy of Agricultural Sciences), Yinfeng Zhang(Tianjin Central Hospital of Gynecology Obstetrics), William Clarke(Johns Hopkins University), Irving Hoffman(Communities In Schools of Orange County), Mariia Liulchuk(National Academy of Sciences of Ukraine)
Cited by 13
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557